Using Lncbase, we predicted that ZFAS1 targets miR-588 in DN which abnormal expression has been reported to be involved in the pathogenesis of prostate cancer [14], human breast cancer [15], colorectal cancer [16], hepatocellular carcinoma [17], and osteosarcoma [18], but not in DN. Here, ZFAS1 is linked to prostate cancer.